We are pleased to announce that Insight Policy Research was acquired by Westat, effective June 15, 2022. Branded as “Westat Insight,” we are currently operating as a wholly owned subsidiary of Westat and continue to provide our clients with the best-in-class services they have come to expect. Our combined experience now offers expanded expertise in health, education, and social policy as well as deeper methodological skills in survey research, evaluation, data analytics, and technical assistance. Learn more here.
We are pleased to announce that Insight Policy Research was acquired by Westat, effective June 15, 2022. Branded as “Westat Insight,” we are currently operating as a wholly owned subsidiary of Westat and continue to provide our clients with the best-in-class services they have come to expect. Our combined experience now offers expanded expertise in health, education, and social policy as well as deeper methodological skills in survey research, evaluation, data analytics, and technical assistance. Learn more here.
powered by bulletin

The Burden of Medication Nonadherence for Medicaid

August 25, 2020

Medication adherence is a challenge for many Medicaid beneficiaries with chronic medical conditions, and the annual costs of nonadherence can be very high. Insight’s dedicated health team reviewed the literature on medication nonadherence among Medicaid beneficiaries and produced a datagraphic for PhRMA highlighting these outcomes.

View a larger version HERE.

Image